Scientific Reports, 2018 · DOI: 10.1038/s41598-018-31314-8 · Published: September 4, 2018
The original article contained typographical errors in the Introduction section regarding the limitations of direct administration of biological factors to injury sites and the role of miR-222 in axon regeneration. Corrections were made to the Materials and Methods section, specifically under the subheading ‘Aligned PCLEEP fibers’, concerning the synthesis of the PCLEEP copolymer. Errors in the Results and Discussion section related to scaffold analysis, delivery duration of NT-3, the role of microRNAs, and oligodendrocyte precursor cells were corrected.
Ensures the scientific community has access to accurate information regarding the use of scaffolds for drug/gene delivery in spinal cord injury treatment.
Clarifies the roles of biological factors and microRNAs in axon regeneration, aiding future research in this area.
Provides correct references, preventing confusion and misattribution of research findings.